179 related articles for article (PubMed ID: 25074472)
1. Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study.
Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):396-402. PubMed ID: 25074472
[TBL] [Abstract][Full Text] [Related]
2. Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.
Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
J Rheumatol; 2014 Dec; 41(12):2447-51. PubMed ID: 25320223
[TBL] [Abstract][Full Text] [Related]
3. Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study.
Elfishawi M; Rakholiya J; Gunderson TM; Achenbach SJ; Crowson CS; Matteson EL; Turesson C; Wadström K; Weyand C; Koster MJ; Warrington KJ
J Rheumatol; 2023 Apr; 50(4):526-531. PubMed ID: 36521923
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N
Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study.
Tomasson G; Bjornsson J; Zhang Y; Gudnason V; Merkel PA
Scand J Rheumatol; 2019 May; 48(3):213-217. PubMed ID: 30460876
[TBL] [Abstract][Full Text] [Related]
6. Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.
Lo Gullo A; Koster MJ; Crowson CS; Makol A; Ytterberg SR; Saitta A; Salvarani C; Matteson EL; Warrington KJ
PLoS One; 2016; 11(2):e0149579. PubMed ID: 26901431
[TBL] [Abstract][Full Text] [Related]
7. The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009.
Chandran AK; Udayakumar PD; Crowson CS; Warrington KJ; Matteson EL
Scand J Rheumatol; 2015 May; 44(3):215-8. PubMed ID: 25606666
[TBL] [Abstract][Full Text] [Related]
8. The association of gout with incident giant cell arteritis in older adults.
Singh JA; Cleveland JD
Joint Bone Spine; 2019 Mar; 86(2):219-224. PubMed ID: 29885976
[TBL] [Abstract][Full Text] [Related]
9. Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
Koster MJ; Achenbach SJ; Crowson CS; Maradit-Kremers H; Matteson EL; Warrington KJ
J Rheumatol; 2017 Jul; 44(7):1044-1050. PubMed ID: 28461641
[TBL] [Abstract][Full Text] [Related]
10. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
[TBL] [Abstract][Full Text] [Related]
11. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
12. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.
Ungprasert P; Upala S; Sanguankeo A; Warrington KJ
Mod Rheumatol; 2016; 26(3):410-4. PubMed ID: 26381748
[TBL] [Abstract][Full Text] [Related]
13. Cancer preceding giant cell arteritis: a case-control study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Ytterberg SR; Matteson EL; Gabriel SE; Warrington KJ
Arthritis Rheum; 2010 Jun; 62(6):1763-9. PubMed ID: 20191583
[TBL] [Abstract][Full Text] [Related]
14. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
15. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
[TBL] [Abstract][Full Text] [Related]
16. Malignancy risk in patients with giant cell arteritis: a population-based cohort study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):149-54. PubMed ID: 20191512
[TBL] [Abstract][Full Text] [Related]
17. Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.
Schäfer VS; Kermani TA; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Rheumatology (Oxford); 2010 Nov; 49(11):2104-8. PubMed ID: 20627970
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.
Chen JJ; Leavitt JA; Fang C; Crowson CS; Matteson EL; Warrington KJ
Ophthalmology; 2016 Sep; 123(9):1999-2003. PubMed ID: 27297405
[TBL] [Abstract][Full Text] [Related]
19. Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with longterm followup.
Espitia O; Néel A; Leux C; Connault J; Espitia-Thibault A; Ponge T; Dupas B; Barrier JH; Hamidou MA; Agard C
J Rheumatol; 2012 Nov; 39(11):2157-62. PubMed ID: 22984271
[TBL] [Abstract][Full Text] [Related]
20. Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.
Michet CJ; Achenbach SJ; Crowson CS; Matteson EL
Semin Arthritis Rheum; 2015 Aug; 45(1):70-4. PubMed ID: 25824865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
